If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
529.00    -1.00 (-0.19%)
Bid:
530.00
Ask:
533.00
Spread: 3.00 (0.566%)
Market Cap: £304.78m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

EBT Share Purchase

22 Jul 2025 17:59

RNS Number : 1319S
Mortgage Advice Bureau (Hldgs) PLC
22 July 2025
 

22 July 2025

 

 

Mortgage Advice Bureau (Holdings) plc

(the "Company")

 

EBT Share Purchase

The Company has been notified that Equiniti Share Plan Trustees Limited, the trustee of its Employee Benefit Trust (the "EBT"), has on 18 July 2025 purchased 294 Ordinary Shares of 0.1p each in the Company ("Shares") at a price of 814 pence per Share.

These Shares are to be held in the EBT and are intended to be used to satisfy the awards of shares granted to employees of the Company as part of the Share Incentive Plan. The EBT is a discretionary trust for the benefit of the Company's employees, including the Directors of the Company.

Enquiries:

 

Mortgage Advice Bureau (Holdings) plc

Via Camarco

Peter Brodnicki, Chief Executive Officer

Ben Thompson, Deputy Chief Executive Officer

Emilie McCarthy, Chief Financial Officer

Nominated Adviser and Joint Broker

Keefe, Bruyette & Woods, a Stifel Company

Erik Anderson / Nick Harland / Francis North

 

+44 (0)20 7710 7600

Joint Broker

Berenberg

James Felix / Michael Burke / Dan Gee-Summons

+44 (0) 20 3207 7800

Joint Broker

Peel Hunt LLP

Andrew Buchanan / Oliver Jackson / Rob Parker

 

+44 (0) 20 7418 8900

Financial PR

Camarco

Tom Huddart / Louise Dolan / Letaba Rimell

 

mab@camarco.co.uk

+44 (0) 203 757 4980

Investor Relations

Investor.relations@mab.org.uk

 

About Mortgage Advice Bureau (Holdings) plc:

 

MAB is one of the UK's leading consumer intermediary brands and specialist networks for mortgage advisers. 

 

Through its partner firms known as Appointed Representatives ("ARs"), MAB has approximately 2,000 advisers providing expert advice to customers on a range of mortgage, specialist lending, protection, and general insurance products. MAB supports its AR firms with proprietary technology and services, including adviser recruitment and lead generation, learning and development, compliance auditing and supervision, and digital marketing and website solutions.

 

For more information, visit www.mortgageadvicebureau.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPUAAMUPAGQP
Date   Source Headline
14th Oct 20165:31 pmRNSDirector/PDMR Shareholding
4th Oct 20165:34 pmRNSHolding(s) in Company
3rd Oct 20163:34 pmRNSHolding(s) in Company
3rd Oct 20167:00 amRNSDirector/PDMR Shareholding
28th Sep 20167:00 amRNSInterim Results
15th Sep 20167:00 amRNSDirectors' Shareholdings and PDMR Notification
31st Aug 201612:14 pmRNSDirector/PDMR Shareholding
15th Aug 20164:13 pmRNSDirectors' Shareholdings and PDMR Notification
10th Aug 20167:00 amRNSPresentation at Canaccord Growth Conference Boston
1st Aug 20167:00 amRNSCompletion of sale stake Capital Private Finance
29th Jul 20162:27 pmRNSDirectors' Shareholdings and PDMR Notification
28th Jul 20167:00 amRNSPre-close Trading Update
14th Jul 20164:53 pmRNSDirectors' Shareholdings and PDMR Notification
30th Jun 20162:00 pmRNSDirector/PDMR Shareholding
27th Jun 20161:27 pmRNSPost referendum outcome comment
14th Jun 20165:45 pmRNSDirectors' Shareholdings
1st Jun 20165:14 pmRNSDirectors' Shareholdings
31st May 20163:22 pmRNSDirectors' Shareholdings
26th May 20163:58 pmRNSResult of AGM
26th May 20167:00 amRNSAGM Statement
16th May 20165:52 pmRNSDirectors' Shareholdings
6th May 20162:51 pmRNSHolding(s) in Company
4th May 20165:45 pmRNSGrant of options
29th Apr 20164:00 pmRNSDirectors' Shareholdings
28th Apr 20165:08 pmRNSHolding(s) in Company
27th Apr 201610:26 amRNSResult of secondary placing of existing shares
27th Apr 20167:00 amRNSProposed secondary placing of existing shares
18th Apr 20167:00 amRNSPosting of Report and Accounts and Notice of AGM
14th Apr 20166:11 pmRNSDirector/PDMR Shareholding
31st Mar 20166:15 pmRNSDirectors' Shareholdings
29th Mar 201611:43 amRNSHolding(s) in Company
24th Mar 20167:00 amRNSHolding(s) in Company
22nd Mar 20167:00 amRNSFinal Results
14th Mar 20164:01 pmRNSDirector/PDMR Shareholding
29th Feb 20163:11 pmRNSDirector/PDMR Shareholding
15th Feb 20163:58 pmRNSDirector/PDMR Shareholding
29th Jan 201611:34 amRNSDirector/PDMR Shareholding
21st Jan 20167:00 amRNSAppointment of Nominated Adviser and Joint Broker
21st Jan 20167:00 amRNSPre-Close Trading Update
14th Jan 20162:40 pmRNSDirector/PDMR Shareholding
24th Dec 201512:05 pmRNSDirector/PDMR Shareholding
14th Dec 20155:05 pmRNSDirector/PDMR Shareholding
11th Dec 20157:00 amRNSInvestment in Sort Limited
30th Nov 20152:15 pmRNSDirector/PDMR Shareholding
29th Oct 20156:22 pmRNSDirector/PDMR Shareholding
30th Sep 20152:10 pmRNSDirector/PDMR Shareholding
24th Sep 20157:00 amRNSInterim Results & Purchase of Head Office Building
28th Aug 201510:21 amRNSDirector/PDMR Shareholding
30th Jul 20152:44 pmRNSDirector/PDMR Shareholding
23rd Jul 20157:00 amRNSPre-close Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.